Baden, Austria

Thomas Von Ruden

This inventor holds 3 USPTO granted patents. Top assignee: Dr. Karl Thomae Gmbh. Active years: 1998-1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thomas Von Ruden. Retrieved from https://idiyas.com/inventor/thomas-von-ruden

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 44(Granted Patents)


Location History:

  • Wien, AT (1998)
  • Baden, AT (1998 - 1999)

Company Filing History:


Years Active: 1998-1999

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Thomas Von Ruden: Innovator in Pharmaceutical Patents

Introduction

Thomas Von Ruden is a notable inventor based in Baden, Austria. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target signal transduction pathways.

Latest Patents

Thomas holds 3 patents related to Pyrimido[5,4-d]pyrimidines. His latest patents focus on pharmaceuticals containing these compounds, which exhibit an inhibitory effect on signal transduction mediated by tyrosine kinases. These inventions are particularly relevant for the treatment of oncoses, showcasing their potential in cancer therapy.

Career Highlights

Thomas is associated with Dr. Karl Thomae GmbH, where he has been instrumental in advancing pharmaceutical research. His work has led to the development of innovative compounds that have therapeutic applications.

Collaborations

Throughout his career, Thomas has collaborated with notable colleagues, including Thomas Metz and Frank Himmelsbach. These partnerships have contributed to the success of his research and patent developments.

Conclusion

Thomas Von Ruden is a distinguished inventor whose work in pharmaceuticals has the potential to impact cancer treatment significantly. His innovative patents and collaborations highlight his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…